Literature DB >> 16816003

Immunizations for patients with metabolic disorders.

Jeffrey D Kingsley1, Meera Varman, Archana Chatterjee, Rae A Kingsley, Karl S Roth.   

Abstract

Individuals with underlying metabolic disorders are a potential high-risk group for vaccine-preventable diseases. Newborn metabolic screening has provided a means of early identification and treatment for many of these disorders, whereas childhood immunization is one of the most effective means of decreasing the morbidity and mortality resulting from communicable diseases worldwide. There are very few contraindications to the routine administration of vaccines to the healthy, immunocompetent individual. In certain high-risk groups, such as immunocompromised patients, gravid females, and those with a history of previous anaphylactic reaction to a vaccine or its components, selective withholding of immunizations must be considered to decrease potential adverse events. A detailed analysis of the medical literature revealed few specific recommendations regarding appropriate immunization techniques for patients with metabolic disorders. In this review we detail the major metabolic disorder subtypes, elaborate on the available literature on immunizations for patients with these disorders, and provide suggested vaccine recommendations.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16816003     DOI: 10.1542/peds.2005-1257

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  4 in total

1.  Vaccines are not associated with metabolic events in children with urea cycle disorders.

Authors:  Thomas M Morgan; Cameron Schlegel; Kathryn M Edwards; Teresa Welch-Burke; Yuwei Zhu; Robert Sparks; Marshall Summar
Journal:  Pediatrics       Date:  2011-04-11       Impact factor: 7.124

Review 2.  Application of pharmacogenomics to vaccines.

Authors:  Gregory A Poland; Inna G Ovsyannikova; Robert M Jacobson
Journal:  Pharmacogenomics       Date:  2009-05       Impact factor: 2.533

3.  Immunological Memory and Affinity Maturation After Vaccination in Patients With Propionic Acidemia.

Authors:  Manuela Zlamy; Thomas Zöggeler; Magdalena Bachmann; Michael Schirmer; Christian Lechner; Miriam Michel; Alexander Schimkowitsch; Daniela Karall; Sabine Scholl-Bürgi
Journal:  Front Immunol       Date:  2022-03-25       Impact factor: 7.561

4.  Causality assessment of adverse events following immunization: the problem of multifactorial pathology.

Authors:  Paolo Bellavite
Journal:  F1000Res       Date:  2020-03-09
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.